GenesisCare has partnered with Novocure to become the first private provider in the UK to offer Optune Gio® as a standard for newly diagnosed WHO Grade 4 Glioma patients, meaning they can access the treatment without needing to self-advocate to insurers. Optune Gio® is a portable CE-marked medical device that delivers alternating electric fields, known…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
